| __timestamp | ImmunityBio, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4326000 | 1244910 |
| Thursday, January 1, 2015 | 226206000 | 5029636 |
| Friday, January 1, 2016 | 94391000 | 4846776 |
| Sunday, January 1, 2017 | 53821000 | 5329003 |
| Monday, January 1, 2018 | 35463000 | 7121000 |
| Tuesday, January 1, 2019 | 46456000 | 9128000 |
| Wednesday, January 1, 2020 | 71318000 | 10731000 |
| Friday, January 1, 2021 | 135256000 | 10701000 |
| Saturday, January 1, 2022 | 102708000 | 16121000 |
| Sunday, January 1, 2023 | 129620000 | 37021000 |
Unlocking the unknown
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of two prominent biotech firms: ImmunityBio, Inc. and Viking Therapeutics, Inc., from 2014 to 2023.
ImmunityBio, Inc. has seen a significant fluctuation in its SG&A expenses, peaking in 2015 with a staggering 2.26 billion, then stabilizing around 1.3 billion in recent years. This represents a 43% increase from its lowest point in 2018. In contrast, Viking Therapeutics, Inc. has maintained a more consistent trajectory, with expenses growing steadily from 1.2 million in 2014 to 37 million in 2023, marking a 29-fold increase.
These trends highlight the differing strategies and growth phases of these companies, offering valuable insights into their operational efficiencies and market positioning.
Johnson & Johnson or ImmunityBio, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Sanofi or Viking Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Gilead Sciences, Inc. and Viking Therapeutics, Inc.
United Therapeutics Corporation or ImmunityBio, Inc.: Who Manages SG&A Costs Better?
Incyte Corporation and Viking Therapeutics, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Insmed Incorporated vs ImmunityBio, Inc.
Who Optimizes SG&A Costs Better? Apellis Pharmaceuticals, Inc. or Viking Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Viking Therapeutics, Inc. and MorphoSys AG
Viking Therapeutics, Inc. and Evotec SE: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing ACADIA Pharmaceuticals Inc. and ImmunityBio, Inc.
ImmunityBio, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? ImmunityBio, Inc. or Iovance Biotherapeutics, Inc.